A+H or an additional listing: Mindray Medical’s plan to go public in Hong Kong is indeed “ready to go.”

```

The "A+H" trend continues to gain momentum.

Recently, market sources reported that Mindray Medical (300760.SZ) has selected Huatai Securities and JPMorgan Chase to handle the preparation work for its Hong Kong IPO, and may bring in more investment banks later.

Wallstreetcn·Xinfeng has confirmed with sources close to Mindray Medical that this news is true; Mindray Medical is indeed preparing to list in Hong Kong.

This is another A-share medical company with a market cap over 100 billion RMB targeting the Hong Kong Stock Exchange, following pharmaceutical giant Hengrui Medicine (600276.SH) joining the Hong Kong market in May this year. As of September 17, Mindray Medical's total market value was about 290 billion RMB.

However, the market may not be surprised by this.

On one hand, since last year, with the popularity of "A+H" listings rising, there have been speculations about whether the two leading A-share medical device companies, Mindray Medical and United Imaging Healthcare (688271.SH), would go public in Hong Kong—at that time, United Imaging Healthcare responded that they had no such plans for now.

On the other hand, due to domestic business pressure in the first half of 2025, Mindray Medical’s overall revenue shrank by nearly 20 percent, but its international business now accounts for 50 percent, becoming a key factor for future performance growth.

From this perspective, listing in Hong Kong does help enhance Mindray Medical’s global brand influence.

The market is now watching to see which other large-cap A-share companies will head for the Hong Kong stock market.

Risk warning and disclaimerThe market involves risk, and investment should be cautious. This article does not constitute personal investment advice, nor does it take into account the specific investment objectives, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their particular circumstances. Investing based on this is at your own risk. ```